CN1160399A - 苯并吡喃和苯并稠合化合物、其制备方法和它们作为白三烯b4(ltb4)拮抗剂的用途 - Google Patents

苯并吡喃和苯并稠合化合物、其制备方法和它们作为白三烯b4(ltb4)拮抗剂的用途 Download PDF

Info

Publication number: CN1160399A
Authority: CN; China
Prior art keywords: alkyl; phenyl; compound; perfluoroalkyl; hydrogen
Prior art date: 1994-10-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

CN95195608A

Other languages

English (en)

Chinese (zh)

Inventor

马克·A·多姆布罗斯基

凯文·科克

安东尼·D·皮斯科皮奥

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pfizer Inc

Original Assignee

Pfizer Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-13

Filing date

1995-05-26

Publication date

1997-09-24

1995-05-26 Application filed by Pfizer Inc filed Critical Pfizer Inc

1997-09-24 Publication of CN1160399A publication Critical patent/CN1160399A/zh

Status Pending legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/42—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4
- C07D311/56—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms in positions 2 and 4 without hydrogen atoms in position 3
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/12—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings
- C07C39/14—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic with no unsaturation outside the aromatic rings with at least one hydroxy group on a condensed ring system containing two rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Transplantation (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pyrane Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

CN95195608A 1994-10-13 1995-05-26 苯并吡喃和苯并稠合化合物、其制备方法和它们作为白三烯b4(ltb4)拮抗剂的用途 Pending CN1160399A (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US32287694A	1994-10-13	1994-10-13
US08/322,876		1994-10-13

Publications (1)

Publication Number	Publication Date
CN1160399A true CN1160399A (zh)	1997-09-24

Family

ID=23256829

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CN95195608A Pending CN1160399A (zh)	1994-10-13	1995-05-26	苯并吡喃和苯并稠合化合物、其制备方法和它们作为白三烯b4(ltb4)拮抗剂的用途

Country Status (23)

Country	Link
US (2)	US6051601A (2)
EP (1)	EP0785930A1 (2)
JP (1)	JP2983295B2 (2)
KR (1)	KR100232341B1 (2)
CN (1)	CN1160399A (2)
AU (1)	AU696890B2 (2)
BR (1)	BR9504385A (2)
CA (1)	CA2201742A1 (2)
CO (1)	CO4480024A1 (2)
CZ (1)	CZ111797A3 (2)
FI (1)	FI971524A0 (2)
HU (1)	HUT77515A (2)
IL (1)	IL115529A0 (2)
MX (1)	MX9702731A (2)
NO (1)	NO971672L (2)
NZ (1)	NZ285156A (2)
PE (1)	PE10897A1 (2)
PL (1)	PL319688A1 (2)
RU (1)	RU2128655C1 (2)
TR (1)	TR199501270A2 (2)
TW (1)	TW304941B (2)
WO (1)	WO1996011920A1 (2)
ZA (1)	ZA958597B (2)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102920692A (zh) *	2012-10-25	2013-02-13	中国人民解放军第二军医大学	(e)-2-(1-羟基-4-环己酮)乙基咖啡酸酯在制备防治类风湿关节炎的药物中的应用
CN119700747A (zh) *	2025-02-26	2025-03-28	云南农业大学	苦杏碱醇a在制备防治骨质疏松症产品中的应用

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL332351A1 (en) *	1996-09-16	1999-09-13	Pfizer	Methods of and intermediate compounds for obtaining substitute derivatives of chromanol
US5817684A (en) *	1996-12-13	1998-10-06	Eli Lilly And Company	Leukotriene antagonists for use in the treatment or inhibition of cerebral focal stroke
IL128731A0 (en) *	1998-03-12	2000-01-31	Pfizer Prod Inc	Method of preventing allograft rejection
EP0963755A3 (en) *	1998-04-16	2001-03-14	Pfizer Products Inc.	Use of benzopyranes for preventing allograft rejection
SE0004245D0 (sv)	2000-11-20	2000-11-20	Pharmacia Ab	Novel compounds and their use
WO2002060888A1 (en) *	2001-01-30	2002-08-08	Pfizer Products Inc.	Processes for preparing chromanylbenzoic acids
AU4239302A (en) *	2001-06-28	2003-01-02	Pfizer Products Inc.	Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
CN100484933C (zh)	2002-06-19	2009-05-06	比奥维特罗姆股份公开公司	新的吡嗪化合物及其在制备用于治疗与5-羟色胺相关的疾病的药物中的用途
BRPI0513695A (pt) *	2004-07-22	2008-05-13	Pharmacia Corp	composições para o tratamento de inflamação e dor que empregam uma combinação de um inibidor seletivo de cox-2 e um antagonista de receptor ltb4
US7674822B2 (en)	2004-11-24	2010-03-09	Wyeth	PTP1b inhibitors
JP2008523145A (ja)	2004-12-13	2008-07-03	イーライリリーアンドカンパニー	リポキシゲナーゼ阻害剤としてのスピロ誘導体
CA2600004A1 (en)	2005-02-25	2006-09-08	Eli Lilly And Company	Spiro-heterocyclic chromans, thiochromans and dihydroquinolines
US7842713B2 (en) *	2006-04-20	2010-11-30	Pfizer Inc	Fused phenyl amido heterocyclic compounds
JP2009536954A (ja)	2006-05-11	2009-10-22	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	Ｃｅｔｐ阻害剤としての３，４−ジヒドロ−２ｈ−ベンゾ［１，４］オキサジンおよびチアジン誘導体
CA2651942A1 (en)	2006-05-11	2008-07-03	Janssen Pharmaceutica N.V.	1,2,3,4-tetrahydro-quinoline derivatives as cetp inhibitors
KR101258331B1 (ko)	2008-09-11	2013-04-26	화이자 인코포레이티드	헤테로아릴 아미드 유도체 및 글루코키나제 활성화제로서의 그의 용도
MY151246A (en) *	2009-03-11	2014-04-30	Pfizer	Benzofuranyl derivatives
EP2814494B1 (en)	2012-02-14	2019-08-21	Children's Hospital Medical Center	Use of small molecule inhibitors targeting the interaction between rac gtpase and p67 (phox)
US9745253B2 (en)	2015-03-13	2017-08-29	Forma Therapeutics, Inc.	Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
AR105911A1 (es)	2015-09-03	2017-11-22	Forma Therapeutics Inc	Inhibidores de hdac8 bicíclicos fusionados [6,6]
WO2017095723A1 (en)	2015-11-30	2017-06-08	Merck Sharp & Dohme Corp.	Aryl acylsulfonamides as blt1 antagonists
EP3383869B1 (en)	2015-11-30	2023-06-28	Merck Sharp & Dohme LLC	Aryl sulfonamides as blt1 antagonists
WO2017095722A1 (en)	2015-11-30	2017-06-08	Merck Sharp & Dohme Corp.	Aryl acylsulfonamides as blt1 antagonists
WO2017095724A1 (en)	2015-11-30	2017-06-08	Merck Sharp & Dohme Corp.	Aryl sulfonamides as blt1 antagonists
WO2018071687A1 (en) *	2016-10-13	2018-04-19	The Regents Of The University Of California	Methods of treating pruritis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SU469247A3 (ru) *	1972-01-14	1975-04-30	Майлз Лабораториз Инк (Фирма)	Способ получени производных хромона
US4565882A (en) *	1984-01-06	1986-01-21	G. D. Searle & Co.	Substituted dihydrobenzopyran-2-carboxylates
CA1320490C (en) *	1987-01-12	1993-07-20	Darrel M. Gapinski	Anti-inflammatory agents
US4889871A (en) *	1987-05-29	1989-12-26	G. D. Searle & Co.	Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
CA2019335C (en) *	1989-06-27	2000-08-01	Mitoshi Konno	Phenylalkan (en)oic acids
US4996230A (en) *	1990-02-16	1991-02-26	Eli Lilly And Company	Leukotriene antagonists
US5073562A (en) *	1990-05-10	1991-12-17	G. D. Searle & Co.	Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof
US5051438A (en) *	1990-05-16	1991-09-24	G. D. Searle & Co.	Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof, compositions and use
US5124350A (en) *	1990-06-28	1992-06-23	G. D. Searle & Co.	Leukotriene b4 antagonists
HUT67929A (en) *	1992-01-23	1995-05-29	Pfizer	Benzopyran and related ltb4 antagonists
MX9300312A (es) *	1992-01-23	1993-07-31	Pfizer	Antagonistas benzopiranicos y relacionado de ltb.

1995
- 1995-05-26 CZ CZ971117A patent/CZ111797A3/cs unknown
- 1995-05-26 CA CA002201742A patent/CA2201742A1/en not_active Abandoned
- 1995-05-26 AU AU24167/95A patent/AU696890B2/en not_active Ceased
- 1995-05-26 PL PL95319688A patent/PL319688A1/xx unknown
- 1995-05-26 EP EP95918114A patent/EP0785930A1/en not_active Withdrawn
- 1995-05-26 WO PCT/IB1995/000401 patent/WO1996011920A1/en not_active Ceased
- 1995-05-26 JP JP8513057A patent/JP2983295B2/ja not_active Expired - Lifetime
- 1995-05-26 MX MX9702731A patent/MX9702731A/es unknown
- 1995-05-26 HU HU9702048A patent/HUT77515A/hu unknown
- 1995-05-26 CN CN95195608A patent/CN1160399A/zh active Pending
- 1995-05-26 NZ NZ285156A patent/NZ285156A/xx unknown
- 1995-05-26 US US08/809,728 patent/US6051601A/en not_active Expired - Fee Related
- 1995-05-26 RU RU97105834A patent/RU2128655C1/ru active
- 1995-05-26 KR KR1019970702392A patent/KR100232341B1/ko not_active Expired - Fee Related
- 1995-10-04 CO CO95046243A patent/CO4480024A1/es unknown
- 1995-10-06 IL IL11552995A patent/IL115529A0/xx unknown
- 1995-10-10 PE PE1995281391A patent/PE10897A1/es not_active Application Discontinuation
- 1995-10-11 BR BR9504385A patent/BR9504385A/pt not_active Application Discontinuation
- 1995-10-12 ZA ZA958597A patent/ZA958597B/xx unknown
- 1995-10-13 TR TR95/01270A patent/TR199501270A2/xx unknown
- 1995-10-13 TW TW084110874A patent/TW304941B/zh active
1997
- 1997-04-11 NO NO971672A patent/NO971672L/no not_active Application Discontinuation
- 1997-04-11 FI FI971524A patent/FI971524A0/fi unknown
2000
- 2000-01-28 US US09/493,707 patent/US6133286A/en not_active Expired - Fee Related

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102920692A (zh) *	2012-10-25	2013-02-13	中国人民解放军第二军医大学	(e)-2-(1-羟基-4-环己酮)乙基咖啡酸酯在制备防治类风湿关节炎的药物中的应用
CN119700747A (zh) *	2025-02-26	2025-03-28	云南农业大学	苦杏碱醇a在制备防治骨质疏松症产品中的应用
CN119700747B (zh) *	2025-02-26	2025-05-06	云南农业大学	苦杏碱醇a在制备防治骨质疏松症产品中的应用

Also Published As

Publication number	Publication date
US6051601A (en)	2000-04-18
AU696890B2 (en)	1998-09-24
NO971672L (no)	1997-06-11
PL319688A1 (en)	1997-08-18
MX9702731A (es)	1997-06-28
PE10897A1 (es)	1997-04-21
RU2128655C1 (ru)	1999-04-10
AU2416795A (en)	1996-05-06
WO1996011920A1 (en)	1996-04-25
NO971672D0 (no)	1997-04-11
TW304941B (2)	1997-05-11
NZ285156A (en)	1999-01-28
ZA958597B (en)	1997-04-14
FI971524A7 (fi)	1997-04-11
BR9504385A (pt)	1997-05-27
CO4480024A1 (es)	1997-07-09
FI971524A0 (fi)	1997-04-11
CA2201742A1 (en)	1996-04-25
KR970706270A (ko)	1997-11-03
JP2983295B2 (ja)	1999-11-29
HUT77515A (hu)	1998-05-28
IL115529A0 (en)	1996-01-19
TR199501270A2 (tr)	1996-06-21
CZ111797A3 (cs)	1998-07-15
JPH09512035A (ja)	1997-12-02
US6133286A (en)	2000-10-17
EP0785930A1 (en)	1997-07-30
KR100232341B1 (ko)	2000-07-01

Legal Events

Date	Code	Title
1997-09-24	C06	Publication
1997-09-24	PB01	Publication
1997-10-08	C10	Entry into substantive examination
1997-10-08	SE01	Entry into force of request for substantive examination
2004-06-16	C02	Deemed withdrawal of patent application after publication (patent law 2001)
2004-06-16	WD01	Invention patent application deemed withdrawn after publication

Publication	Publication Date	Title
CN1160399A (zh)	1997-09-24	苯并吡喃和苯并稠合化合物、其制备方法和它们作为白三烯b4(ltb4)拮抗剂的用途
CN1166834A (zh)	1997-12-03	苯并吡喃和苯并稠合化合物，其制备方法和它们作为白三烯b4(ltb4)拮抗剂的用途
CN1037439C (zh)	1998-02-18	制备具有神经保护作用的吲哚酮及有关衍生物的方法
CN1052723C (zh)	2000-05-24	用作治疗剂的双环芳族化合物、其制法及含有该化合物的药物组合物
CN1340048A (zh)	2002-03-13	异黄酮衍生物的制备
AU626490B2 (en)	1992-07-30	Neuroprotective 3-piperidino-4-hydroxychroman derivatives
CN1031230A (zh)	1989-02-22	具有类视网膜活性的苯基和杂二环基取代的乙炔及其制备方法
CN87104970A (zh)	1988-02-03	取代的氨基-5，6，7，8-四氢萘基氧代乙酸其制备方法及其作为药物的用途
CN86107627A (zh)	1987-07-15	新颖的4-苄基-1-(2h)-酞嗪酮衍生物的制备方法
CN1553915A (zh)	2004-12-08	制备六氢-呋喃并[2,3-b]呋喃-3-醇的方法
EP0623123B1 (en)	1997-04-23	Benzopyran and related LTB4-antagonists
CN1214048A (zh)	1999-04-14	具有白细胞三烯拮抗作用的苯并吡喃衍生物
CN1071755C (zh)	2001-09-26	杂环甲酰胺衍生物及其作为治疗剂的用途
CN1040440C (zh)	1998-10-28	去氢环黄皮酰胺衍生物的制备方法
HK1000245B (en)	1998-02-13	Benzopyran and related ltb4-antagonists
CN1118783A (zh)	1996-03-20	新的吡啶并[3，2-b][1，5]苯并硫代吖庚因的制备方法
CN1058207A (zh)	1992-01-29	新的哌啶化合物及其制备方法
CN1123546A (zh)	1996-05-29	4-芳基异吲哚止痛药
CN1043128A (zh)	1990-06-20	取代的咪唑衍生物及其制备
CN1033277A (zh)	1989-06-07	治疗气喘用的取代的四氢化萘苯并二氢吡喃和有关化合物
CN1535274A (zh)	2004-10-06	抗抑郁的(SSSRI)7,8-二氢-3H-6,9-二氧杂-1,3-二氮杂环戊二烯并[a]萘的氮杂环基甲基衍生物
CN1228082A (zh)	1999-09-08	双吲哚基马来酰亚胺的合成
CN1117729A (zh)	1996-02-28	吗啉衍生物
CN1102644A (zh)	1995-05-17	缩合吡啶型甲羟戊酸内酯中间体及其制备方法
CN87102452A (zh)	1987-10-14	1、4-二氢吡啶-3、5-二羧酸的不对称酯的衍生物